Pyridostigmine is a drug that has received approval by the U.S. Food and Drug Administration (FDA) under the brand name Mestinon to treat a condition called myasthenia gravis and under the brand name Regonol to reverse the effects of muscle relaxants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include N, N-dimethyl(1-methyl(3-pyridyloxy))carboxamide and Pyridostigmine Bromine. Its PubChem CID is 4991.
Pyridostigmine
| CAS No | 155-97-5 |
|---|---|
| Molecular Formula | C9H13N2O2+ |
| Molecular Weight | 181.21 g/mol |
| Synonyms | (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) under the brand name Mestinon to treat a condition called myasthenia gravis and under the brand name Regonol to reverse the effects of muscle relaxants.
The listed CAS number is 155-97-5.
The listed molecular formula is C9H13N2O2+.
The listed molecular weight is 181.21 g/mol.
(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate.
The source lists N, N-dimethyl(1-methyl(3-pyridyloxy))carboxamide and Pyridostigmine Bromine.